251 related articles for article (PubMed ID: 35782375)
1. Prevention of hepatocellular carcinoma and monitoring of high-risk patients.
Kaya E; Daniel Mazzolini G; Yilmaz Y; Canbay A
Hepatol Forum; 2022 Jan; 3(1):33-38. PubMed ID: 35782375
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
Desai A; Sandhu S; Lai JP; Sandhu DS
World J Hepatol; 2019 Jan; 11(1):1-18. PubMed ID: 30705715
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
Fares N; Péron JM
Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
[TBL] [Abstract][Full Text] [Related]
5. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.
Suresh D; Srinivas AN; Kumar DP
Front Oncol; 2020; 10():601710. PubMed ID: 33330100
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
[TBL] [Abstract][Full Text] [Related]
7. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma.
Llovet JM; Zucman-Rossi J; Pikarsky E; Sangro B; Schwartz M; Sherman M; Gores G
Nat Rev Dis Primers; 2016 Apr; 2():16018. PubMed ID: 27158749
[TBL] [Abstract][Full Text] [Related]
9. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.
Samant H; Amiri HS; Zibari GB
J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S361-S373. PubMed ID: 34422400
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.
Tovoli F; Ferri S; Piscaglia F
Curr Pharm Des; 2020; 26(32):3909-3914. PubMed ID: 32348210
[TBL] [Abstract][Full Text] [Related]
13. Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.
Gambarin-Gelwan M
Chin Clin Oncol; 2013 Dec; 2(4):32. PubMed ID: 25841911
[TBL] [Abstract][Full Text] [Related]
14. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
[TBL] [Abstract][Full Text] [Related]
15. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
Singal AG; Lim JK; Kanwal F
Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
[TBL] [Abstract][Full Text] [Related]
18. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma surveillance: An evidence-based approach.
Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
[TBL] [Abstract][Full Text] [Related]
20. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
